Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TimoD implant
- Development stage
- Unknown
- Lead developer
- EyeD Pharma
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems
- Administration
- Ophthalmic
01
Overview
TimoD implant is an investigational intraocular implant designed for the sustained release of Timolol, an approved medicine, into the eye. It is being developed for the treatment of primary open-angle glaucoma and ocular hypertension. The implant aims to provide a new method for delivering Timolol, a non-selective beta-adrenergic blocker, to reduce intraocular pressure.
- Brand names
- TimoD
- Other names
- TimoD implantTimolol sustained-release intraocular implant
02
Targets
ADRB2 (β2)ADRB1 (β1)
Beyond the preview
Go deeper on TimoD implant.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TimoD implant.